Company / Income Tax per Share
RAPT Therapeutics, Inc. Income Tax per Share History
FY2019-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.04
FY2020
5-year range
$0.04 / $0.04
FY2019-FY2020
Trend
-73.0%
vs FY2019
Sector context
#57 of 194
Health Care
What the data says
At $0.04, RAPT Therapeutics, Inc.'s income tax per share ranks #138 of 194 in the Health Care sector.
Based on SEC 10-K filings.
0.04 in FY2020.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#138 of 194 in Health CareTop 71% of 194This company $0.04 Sector average $1.44
▼
-97.1% below sector average
Key checks
Key Insights
- In FY2020, income tax per share decreased 73.0% year-over-year.
- Ranks #57 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.38 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $0.04 | -73.0% |
| FY2019 | $0.15 | - |
| FY2018 | - | - |
As of FY2020 · SEC 10-K · Updated Feb 28, 2026